Harvard Bioscience, Inc. Reports 2020 Annual Meeting Voting Results

Strategic Insights -

Harvard Bioscience, Inc. held its 2020 Annual Meeting of Stockholders on June 11, 2020, where stockholders voted on several proposals, including the election of two Class II Directors, the ratification of Grant Thornton LLP as the Company's independent registered public accounting firm, the approval of the Company's Fourth Amended and Restated 2000 Stock Option and Incentive Plan, and the approval, by a non-binding advisory vote, of the compensation of the Company's named executive officers. The proposals were voted on by the stockholders, with the results as follows.

Key Takeaways:

  • The stockholders elected Katherine A. Eade and Thomas W. Loewald as Class II Directors, each for a three-year term, with 29,340,460 and 29,243,810 votes in favor, respectively.
  • Grant Thornton LLP was ratified as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020, with 34,535,107 votes in favor and 22,128 votes against.
  • The Company's Fourth Amended and Restated 2000 Stock Option and Incentive Plan, which includes an increase of 3,700,000 authorized shares of common stock and a reduction of the fungible share ratio, was approved with 24,932,042 votes in favor and 4,479,694 votes against.
  • The compensation of the Company's named executive officers was approved by a non-binding advisory vote, with 26,819,612 votes in favor and 2,588,415 votes against.

Statistics:

  • 29,340,460 votes were cast in favor of Katherine A. Eade's election.
  • 29,243,810 votes were cast in favor of Thomas W. Loewald's election.
  • 34,535,107 votes were cast in favor of ratifying Grant Thornton LLP as the Company's independent registered public accounting firm.
  • 24,932,042 votes were cast in favor of approving the Company's Fourth Amended and Restated 2000 Stock Option and Incentive Plan.
  • 26,819,612 votes were cast in favor of approving the compensation of the Company's named executive officers.

Sources:

  • Form 8-K (Current Report), submitted to the Securities and Exchange Commission (SEDAR) on June 15, 2020.
  • United States Securities and Exchange Commission, Washington, D.C. 20549.